CN1772149A - Chinese medicine composition for treating coronary heart disease and its prepn - Google Patents
Chinese medicine composition for treating coronary heart disease and its prepn Download PDFInfo
- Publication number
- CN1772149A CN1772149A CNA2005101153024A CN200510115302A CN1772149A CN 1772149 A CN1772149 A CN 1772149A CN A2005101153024 A CNA2005101153024 A CN A2005101153024A CN 200510115302 A CN200510115302 A CN 200510115302A CN 1772149 A CN1772149 A CN 1772149A
- Authority
- CN
- China
- Prior art keywords
- radix
- heart disease
- coronary heart
- chinese medicine
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The Chinese medicine composition for treating coronary heart disease is prepared with 14 kinds of Chinese medicinal materials, including dalbergia wood, sandalwood, Chuanxiong rhizome, angelica, notoginseng, etc. It may be bolus, capsule, tablet or granule. The medicine of present invention has the advantages of high curative effect and less recurrence.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition for the treatment of coronary heart disease and preparation method thereof.
Background technology
Coronary heart disease multiple reason arranged, become disease as labor of a specified duration, anger, also relevant with heredity, mainly be the diet surplus, fat deposits in blood vessel wall, blood vessel elasticity descends, and further forms thrombosis, thereby causes coronary atherosclerosis, myocardial infarction, show as angina pectoris, arrhythmia, arrhythmia, sensation of oppression over the chest with shortness of breath, general weakness, cardiac function descends, and venous return is obstructed, anasarca, cardiac blood supply deficiency is to cause people's death.At present, the medicine of multiple treatment coronary heart disease is arranged on the market, but a variety of curative effect of medication is definite inadequately, perhaps has toxic and side effects in various degree, perhaps ingredient is many, compatibility property of medicine complexity.
Summary of the invention
The invention provides a kind of Chinese medicine composition for the treatment of coronary heart disease and its production and application, have evident in efficacyly, be difficult for the advantage of recurrence.
The objective of the invention is to be achieved through the following technical solutions:
The invention provides a kind of Chinese medicine composition for the treatment of coronary heart disease, is by the preparation that comprises that following middle parts by weight of component raw material is made: Lignum Dalbergiae Odoriferae 50-70, Lignum Santali Albi 50-70, Lignum Aquilariae Resinatum 65-85, Radix Aucklandiae 50-70, Rhizoma Chuanxiong 35-55, Radix Angelicae Sinensis 35-55, Radix Notoginseng 70-90, Scolopendra 3-7, Hirudo 50-70, Radix Paeoniae Rubra 50-70, Semen Arecae 70-90, Moschus 1-3, Radix Salviae Miltiorrhizae 50-70, Flos Carthami 50-70.
Described raw material is preferably following parts by weight of component: Lignum Dalbergiae Odoriferae 60, Lignum Santali Albi 60, Lignum Aquilariae Resinatum 75, the Radix Aucklandiae 60, Rhizoma Chuanxiong 45, Radix Angelicae Sinensis 45, Radix Notoginseng 80, Scolopendra 5, Hirudo 60, Radix Paeoniae Rubra 60, Semen Arecae 80, Moschus 2, Radix Salviae Miltiorrhizae 60, Flos Carthami 60.
Described preparation is multiple oral formulations commonly used, is preferably pill, capsule, tablet, granule.
The present invention also provides a kind of preparation method for the treatment of the Chinese medicine composition of coronary heart disease, may further comprise the steps: press the above-mentioned raw materials component, be total to pulverize, pharmaceutical methods is made pharmaceutical preparation routinely, as pill, capsule, tablet, granule.
Described step comprises that also adding proper honey makes honeyed pill.
Above-mentioned raw materials of the present invention is selected quality raw materials for use.
The Chinese medicine composition function that the present invention treats coronary heart disease cures mainly: activating blood circulation to dissipate blood stasis, remove the blood dirt, and increase blood vessel elasticity, the blood dirt is excreted, it is normal that cardiac function recovers.
Instructions of taking: honeyed pill, every day 1 time, morning (medicine) being taken before meal usefulness, the 1-2g that at every turn is grown up, 10 days is a course of treatment, can cure 1-8 the course of treatment.
Rhizoma Chuanxiong, Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae, Flos Carthami, Radix Paeoniae Rubra activating blood circulation to dissipate blood stasis in the medicine of the present invention; Lignum Santali Albi, Lignum Aquilariae Resinatum, the Radix Aucklandiae, Lignum Dalbergiae Odoriferae, the blood dirt is removed in the pseudo-ginseng blood-circulation-invigovating pain relieving; Scolopendra, Hirudo, Semen Arecae, the silt of sensibleization of Moschus excrete the blood dirt, reach the effect of radical cure.
Medicine of the present invention has the following advantages:
1, ingredient is simple, and good effect is difficult for recurrence, has no side effect taking convenience.
2, the present invention can available energy treat coronary heart disease through multi-argument, recovers the heart normal physiological function.
Be the advantage of proof said medicine, the present invention has carried out embodiment 1 honeyed pill medicine clinical observation.2001-2003, case is chosen 300 routine patients with coronary heart disease, and the men and women half and half, age 30-60 year.Instructions of taking: embodiment 1 honeyed pill, the 1g/ grain, the 2g that at every turn is grown up, every day 1 time, (medicine) being taken before meal is used ante cibum in the morning.
The curative effect judgment criteria: (1) cures: local symptom and General Symptoms disappear, and electrocardiogram is normal, and heart rate is normal; (2) produce effects: local symptom and General Symptoms obviously improve, and electrocardiogram, heart rate obviously improve; (3) effective: local symptom and General Symptoms have improvement, and electrocardiogram, heart rate have improvement; (4) invalid: local symptom and General Symptoms do not improve, and electrocardiogram, heart rate do not have improvement.
Result: cure 267 people, cure rate 89.0%; Produce effects 276 people, obvious effective rate 92.0%; Effective 288 people, effective percentage 96%; Invalid 12 people, inefficiency 4% is not seen recurrent cases after the tracking.
The specific embodiment
Embodiment 1
Honeyed pill
A kind of Chinese medicine composition honey pill agent for the treatment of coronary heart disease is prepared by following raw material (KG): Lignum Dalbergiae Odoriferae 60, Lignum Santali Albi 60, Lignum Aquilariae Resinatum 75, the Radix Aucklandiae 60, Rhizoma Chuanxiong 45, Radix Angelicae Sinensis 45, Radix Notoginseng 80, Scolopendra 5, Hirudo 60, Radix Paeoniae Rubra 60, Semen Arecae 80, Moschus 2, Radix Salviae Miltiorrhizae 60, Flos Carthami 60.
Preparation method: above-mentioned raw materials, pulverize is crossed 60 mesh sieves altogether, adds proper honey and makes honeyed pill, promptly.
Embodiment 2
Capsule
A kind of Chinese medicinal composition capsules agent for the treatment of coronary heart disease is prepared by following raw material (KG): Lignum Dalbergiae Odoriferae 50, Lignum Santali Albi 50, Lignum Aquilariae Resinatum 65, the Radix Aucklandiae 50, Rhizoma Chuanxiong 35, Radix Angelicae Sinensis 35, Radix Notoginseng 70, Scolopendra 3, Hirudo 50, Radix Paeoniae Rubra 50, Semen Arecae 70, Moschus 1, Radix Salviae Miltiorrhizae 50, Flos Carthami 50.
Preparation method: above-mentioned raw materials, pulverize is crossed 100 mesh sieves altogether, and is encapsulated, promptly.
Embodiment 3
Granule
A kind of Chinese medicinal composition granules for the treatment of coronary heart disease is prepared by following raw material (KG): Lignum Dalbergiae Odoriferae 70, Lignum Santali Albi 70, Lignum Aquilariae Resinatum 85, the Radix Aucklandiae 70, Rhizoma Chuanxiong 55, Radix Angelicae Sinensis 55, Radix Notoginseng 90, Scolopendra 7, Hirudo 70, Radix Paeoniae Rubra 70, Semen Arecae 90, Moschus 3, Radix Salviae Miltiorrhizae 70, Flos Carthami 70.
Preparation method: above-mentioned raw materials, pulverize is crossed 80 mesh sieves altogether, pack, promptly.
Embodiment 4
Pill
A kind of Chinese medicine composition pill for the treatment of coronary heart disease is prepared by following raw material (KG): Lignum Dalbergiae Odoriferae 50, Lignum Santali Albi 50, Lignum Aquilariae Resinatum 65, the Radix Aucklandiae 50, Rhizoma Chuanxiong 35, Radix Angelicae Sinensis 35, Radix Notoginseng 70, Scolopendra 3, Hirudo 50, Radix Paeoniae Rubra 50, Semen Arecae 70, Moschus 1, Radix Salviae Miltiorrhizae 50, Flos Carthami 50.
Preparation method: above-mentioned raw materials, pulverize is crossed 60 mesh sieves altogether, makes pill according to a conventional method, promptly.
Claims (5)
1, a kind of Chinese medicine composition for the treatment of coronary heart disease is by the preparation that comprises that following middle parts by weight of component raw material is made: Lignum Dalbergiae Odoriferae 50-70, Lignum Santali Albi 50-70, Lignum Aquilariae Resinatum 65-85, Radix Aucklandiae 50-70, Rhizoma Chuanxiong 35-55, Radix Angelicae Sinensis 35-55, Radix Notoginseng 70-90, Scolopendra 3-7, Hirudo 50-70, Radix Paeoniae Rubra 50-70, Semen Arecae 70-90, Moschus 1-3, Radix Salviae Miltiorrhizae 50-70, Flos Carthami 50-70.
2, according to the Chinese medicine composition of the treatment coronary heart disease of claim 1, described raw material is following parts by weight of component: Lignum Dalbergiae Odoriferae 60, Lignum Santali Albi 60, Lignum Aquilariae Resinatum 75, the Radix Aucklandiae 60, Rhizoma Chuanxiong 45, Radix Angelicae Sinensis 45, Radix Notoginseng 80, Scolopendra 5, Hirudo 60, Radix Paeoniae Rubra 60, Semen Arecae 80, Moschus 2, Radix Salviae Miltiorrhizae 60, Flos Carthami 60.
3, the Chinese medicine composition of treatment coronary heart disease according to claim 1 and 2, described preparation are pill, capsule, tablet, granule.
4, a kind of preparation method for the treatment of the Chinese medicine composition of coronary heart disease, may further comprise the steps: the weighting profit requires 1 or 2 raw material components in proportion, is total to pulverize, and pharmaceutical methods is made pharmaceutical preparation routinely.
5, according to the preparation method of the Chinese medicine composition of the treatment coronary heart disease of claim 4, described step comprises that also adding proper honey makes honeyed pill.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005101153024A CN1326547C (en) | 2005-11-16 | 2005-11-16 | Chinese medicine composition for treating coronary heart disease and its prepn |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005101153024A CN1326547C (en) | 2005-11-16 | 2005-11-16 | Chinese medicine composition for treating coronary heart disease and its prepn |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1772149A true CN1772149A (en) | 2006-05-17 |
| CN1326547C CN1326547C (en) | 2007-07-18 |
Family
ID=36759400
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005101153024A Expired - Fee Related CN1326547C (en) | 2005-11-16 | 2005-11-16 | Chinese medicine composition for treating coronary heart disease and its prepn |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1326547C (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101897753A (en) * | 2010-05-27 | 2010-12-01 | 哈药集团三精制药诺捷有限责任公司 | Traditional Chinese medicine for treating coronary disease and preparation method thereof |
| CN102397349A (en) * | 2011-11-26 | 2012-04-04 | 苏州派腾生物医药科技有限公司 | Method for preparing Xinning tablets |
| CN106309583A (en) * | 2016-11-24 | 2017-01-11 | 厉建刚 | Medicine for treating heart diseases and preparing method |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1124153C (en) * | 2001-08-31 | 2003-10-15 | 石家庄以岭药业股份有限公司 | Medicinal composition for restoring cardiac collaterals and its application |
-
2005
- 2005-11-16 CN CNB2005101153024A patent/CN1326547C/en not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101897753A (en) * | 2010-05-27 | 2010-12-01 | 哈药集团三精制药诺捷有限责任公司 | Traditional Chinese medicine for treating coronary disease and preparation method thereof |
| CN102397349A (en) * | 2011-11-26 | 2012-04-04 | 苏州派腾生物医药科技有限公司 | Method for preparing Xinning tablets |
| CN102397349B (en) * | 2011-11-26 | 2013-04-24 | 苏州派腾生物医药科技有限公司 | Method for preparing Xinning tablets |
| CN106309583A (en) * | 2016-11-24 | 2017-01-11 | 厉建刚 | Medicine for treating heart diseases and preparing method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1326547C (en) | 2007-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100342889C (en) | Chinese medicine for treating gout | |
| CN1240416C (en) | Medicine for curing hypertension and its preparation method | |
| CN1476849A (en) | Medicine composition for promoting blood circulation and removing stasis | |
| CN1872180A (en) | Medication of membranous milk vetch for activating blood and the channels, and preparation method | |
| CN1772149A (en) | Chinese medicine composition for treating coronary heart disease and its prepn | |
| CN101049438A (en) | Composition of Chinese traditional medicine for treating coronary heart disease | |
| CN106729379A (en) | It is a kind of to treat Externally applied Chinese medicine powder of acute gouty arthritis and preparation method thereof | |
| CN1066332C (en) | Hypoglycemic compound capsule | |
| CN1194724C (en) | Chinese medical preparation for treating coronary disease and angina pectoris and preparation thereof | |
| CN1186044C (en) | Chinese medicine 'lidandishi' for treating hepatobiliary calculus and cholecystitis | |
| CN1202847C (en) | Diabetes treating medicine | |
| CN1745795A (en) | Medicine for preventing and treating coronary heart disease and preparation method thereof | |
| CN1045892C (en) | Chinese medicine Guanxintong for preventing and curing coronary heart disease and angina pectoris, and producing process thereof | |
| CN1173718C (en) | Medicine for curing lupus erythematosus etc. immune diseases induced diseases | |
| CN104095940A (en) | Traditional Chinese medicine composition for treating gout | |
| CN103768454A (en) | Composition for preventing and treating HIV/AIDS (Human Immunodeficiency Virus/ Acquired Immune Deficiency Syndrome) and preparation method thereof | |
| CN1247222C (en) | Pharmaceutical composition for treating AlDS | |
| CN1212150C (en) | Medicine for treating virus hepatitis and its preparation method | |
| CN101406495B (en) | Medicament for mainly curing cardiovascular disease | |
| CN1171625C (en) | Mayi-shuangshen Tongbi pill for treating rheumatoid or rheumatic arthitis and ankylosing spondylitis | |
| CN1277559C (en) | Medicine for treating rheumatism and its preparation | |
| CN1853711A (en) | Xinmaikangzhong Chinese medicinal composition and preparation thereof | |
| CN1879760A (en) | Compound medicine for treating high paralysis, fracture sequelae, cardiac infarction and splenomegaly | |
| CN101057949A (en) | Traditional Chinese medicine one-step preparation for treating coronary heart disease | |
| CN100366270C (en) | Medicine for curing cardiovascular and cerebrovascular diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070718 Termination date: 20091216 |